MIT-MGB Seed Program
The MIT-MGB Seed Program funds collaborative MIT and Mass General Brigham research to develop innovative technologies in mental health, AI diagnostics, and digital health for clinical impact.
Funder: Massachusetts Institute of Technology
Due Dates: June 17, 2026 (Initial Proposal Submission Date)
Funding Amounts: Typical seed grants; specific award amounts and durations posted in the application portal.
Summary: Supports collaborative MIT–Mass General Brigham research projects to develop innovative technologies for advancing clinical practice.
Description
The MIT-MGB Seed Program is a joint initiative between the Massachusetts Institute of Technology and Mass General Brigham, established to foster collaborative research projects that have the potential to transform clinical practice through innovative technology development. The program leverages MIT’s strengths in science, engineering, and innovation alongside Mass General Brigham’s clinical and research expertise. Projects are evaluated based on collaborative impact, potential for transformative advances in health and medicine, and the likelihood of translation into real-world clinical practice.
Strategic focus areas for the program include:
- Mental health and neurodegenerative diseases
- AI-enabled diagnostics
- Digital health
The program is supported by Analog Devices Inc. and aims to catalyze impactful partnerships between MIT and Mass General Brigham researchers.
